BEAM THERAPEUTICS INC (BEAM) Stock Analyst Earnings Estimates
NASDAQ:BEAM - Nasdaq - US07373V1052 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 51.84M 259,100.00% | 60.92M 17.52% | 377.709M 520.01% | 52.446M -86.11% | 60.115M 14.62% | 65.075M 8.25% | 76.354M 17.33% | 227.84M 198.40% | 619.57M 171.93% | 1.495B 141.30% | 1.639B 9.63% | 2.01B 22.64% | |
| EBITDA YoY % growth | -385.02M -200.75% | -324.33M 15.76% | -156.473M 51.76% | -416.856M -166.41% | -460.036M -10.36% | -491.976M -6.94% | -347.82M 29.30% | -249.798M 28.18% | -207.57M 16.90% | N/A | N/A | N/A | |
| EBIT YoY % growth | -392.47M -195.62% | -338.48M 13.76% | -176.485M 47.86% | -432.703M -145.18% | -455.619M -5.30% | -480.122M -5.38% | -448.738M 6.54% | -384.554M 14.30% | -142.078M 63.05% | 354.46M 349.48% | 302.3M -14.72% | 449.32M 48.63% | |
| Operating Margin | -757.08% | -555.61% | -46.73% | -825.05% | -757.91% | -737.80% | -587.71% | -168.78% | -22.93% | 23.71% | 18.44% | 22.35% | |
| EPS YoY % growth | -5.94 -44.88% | -4.13 30.47% | -1.90 54.00% | -4.77 -151.11% | -4.86 -1.95% | -4.48 7.81% | -4.28 4.51% | -3.79 11.58% | -2.38 37.10% | 0.20 108.57% | 2.76 1,253.35% | 3.90 41.38% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -1.23 -170.99% | -1.22 -1.16% | -1.23 -10.90% | -1.21 -3.22% | -1.19 2.95% | -0.99 19.17% | -1.03 16.31% | -1.03 14.70% | -1.04 12.71% |
| Revenue Q2Q % growth | 17.269M -94.54% | 15.865M 114.10% | 15.895M 35.02% | 16.129M 13.04% | 16.32M -5.50% | N/A | N/A | N/A | N/A |
| EBITDA Q2Q % growth | -95.816M -162.68% | -100.72M -2.05% | -103.685M -10.43% | -106.831M -18.67% | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -110.998M -183.55% | -110.67M -6.28% | -113.634M -8.33% | -114.341M -7.36% | -120.36M -8.43% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -1.17 4.10% | -1.18 | 0.01 | 0.76% |
| Q2 2024 Q2Q % growth | -1.11 -2.78% | -1.15 | 0.04 | 3.51% |
| Q1 2024 Q2Q % growth | -1.21 9.02% | -1.45 | 0.24 | 16.31% |
| Q4 2023 Q2Q % growth | 1.73 420.37% | -1.03 | 2.76 | 267.72% |
| Q3 2023 Q2Q % growth | -1.22 21.79% | -1.39 | 0.17 | 12.16% |
| Q2 2023 Q2Q % growth | -1.08 -5.88% | -1.45 | 0.37 | 25.68% |
| Q1 2023 Q2Q % growth | -1.33 -31.68% | -1.37 | 0.04 | 2.85% |
| Q4 2022 Q2Q % growth | -0.54 43.16% | -1.35 | 0.81 | 60.13% |
| Q3 2022 Q2Q % growth | -1.56 -271.43% | -1.34 | -0.22 | -16.50% |
| Q2 2022 Q2Q % growth | -1.02 17.07% | -1.10 | 0.08 | 7.25% |
| Q1 2022 Q2Q % growth | -1.01 69.76% | -1.35 | 0.34 | 24.99% |
| Q4 2021 Q2Q % growth | -0.95 43.79% | -1.05 | 0.10 | 9.38% |
| Q3 2021 Q2Q % growth | -0.42 39.13% | -0.75 | 0.33 | 44.10% |
| Q2 2021 Q2Q % growth | -1.23 -78.26% | -0.66 | -0.57 | -86.60% |
| Q1 2021 Q2Q % growth | -3.34 -224.27% | -0.75 | -2.59 | -343.25% |
| Q4 2020 Q2Q % growth | -1.69 62.19% | -0.68 | -1.01 | -146.77% |
| Q3 2020 Q2Q % growth | -0.69 | -0.57 | -0.12 | -21.67% |
| Q2 2020 Q2Q % growth | -0.69 | -0.54 | -0.15 | -28.12% |
| Q1 2020 Q2Q % growth | -1.03 | -0.52 | -0.51 | -99.96% |
| Q4 2019 Q2Q % growth | -4.47 | -0.53 | -3.94 | -737.40% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 14.269M -17.01% | 14.789M | -520K | -3.52% |
| Q2 2024 Q2Q % growth | 11.772M -41.48% | 14.466M | -2.694M | -18.62% |
| Q1 2024 Q2Q % growth | 7.41M -69.39% | 17.307M | -9.897M | -57.18% |
| Q4 2023 Q2Q % growth | 316.192M 1,477.80% | 19.046M | 297.146M | 1,560.15% |
| Q3 2023 Q2Q % growth | 17.193M 8.82% | 17.458M | -265K | -1.52% |
| Q2 2023 Q2Q % growth | 20.116M 20.82% | 18.413M | 1.703M | 9.25% |
| Q1 2023 Q2Q % growth | 24.208M 187.16% | 14.359M | 9.849M | 68.59% |
| Q4 2022 Q2Q % growth | 20.04M -60.76% | 12.989M | 7.051M | 54.28% |
| Q3 2022 Q2Q % growth | 15.8M 1,978.95% | 7.294M | 8.506M | 116.62% |
| Q2 2022 Q2Q % growth | 16.65M 166,400.00% | 8.558M | 8.092M | 94.55% |
| Q1 2022 Q2Q % growth | 8.43M 84,200.00% | 6.024M | 2.406M | 39.94% |
| Q4 2021 Q2Q % growth | 51.07M 510,600.00% | 2.36M | 48.71M | 2,063.98% |
| Q3 2021 Q2Q % growth | 760K 7,500.00% | 7.335M | -6.575M | -89.64% |
| Q2 2021 Q2Q % growth | 10K | 2.04K | 7.96K | 390.20% |
| Q1 2021 Q2Q % growth | 10K | 1.744K | 8.256K | 473.33% |
| Q4 2020 Q2Q % growth | 10K | 2.04K | 7.96K | 390.20% |
| Q3 2020 Q2Q % growth | 10K | 1.53K | 8.47K | 553.59% |
| Q2 2020 Q2Q % growth | 10K | 1.53K | 8.47K | 553.59% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 3.94% | 3.36% | 0.89% | 1% |
| Revenue | 19.36% | 16.18% | 1.13% | 2.42% |